In this nationally representative study of the association between race/ethnicity and IHT for patients hospitalized with common medical diagnoses, we found that Black and Hispanic patients had lower odds of transfer, primarily explained by differences in location of original hospitalization (i.e., Black and Hispanic patients were disproportionally initially hospitalized at urban teaching hospitals). Upon examination of the subset of patients hospitalized at community hospitals, and adjusting for other patient and hospital characteristics, Hispanic ethnicity remained significantly associated with lower odds of transfer. Among these patients, we observed differential adjusted odds of transfer by race within certain regions of the country and among patients with select primary diagnoses. We also found that women and “underinsured” patients (i.e., those with Medicaid or no insurance, compared with Medicare) had significantly lower adjusted odds of transfer. Though prior studies have demonstrated racial/ethnic disparities in various forms of access to medical care,8, 9 this study is among the first to evaluate racial/ethnic disparities in hospital transfer among patients with primary medical diagnoses with the highest frequency of transfer.1 Collectively, our results demonstrate a nuanced view of potential racial/ethnic disparities within IHT.
Although our crude results demonstrated significantly lower IHT rates among Black and Hispanic patients, these differences largely disappeared once adjusting for hospital characteristics. Our findings suggest that IHT practices are predominantly influenced by hospital characteristics and that racial/ethnic differences in transfer rates are largely explained by the fact that Black and Hispanic patients are more likely than White patients to initially present to urban teaching hospitals known to have lower rates of transfer.1, 8 This explanation does not fully account for the persistent disparities observed among Hispanic patients hospitalized at community hospitals, i.e., at hospitals more likely to transfer patients.1 Though much of the limited existing literature on IHT and race/ethnicity is focused on Black versus White patients, other studies have also demonstrated lower transfer rates among Hispanic patients for select conditions that often require transfer to receive specialty care.24, 25, 39, 40 Our findings therefore highlight that such disparities likely persist among a broader population of Hispanic patients with the medical conditions included in this study.
Among patients admitted to community hospitals, our results additionally suggest disparity in transfer by race/ethnicity within select regions in the country, and among patients with select diagnoses. These findings were discovered in our subgroup analyses and therefore should be considered exploratory. Regional variations in IHT practices have been previously described,1, 18, 25 but it is unclear why such variations would confer racial/ethnic disparities in transfer. Limited existing literature on disease-specific IHT is primarily focused on IHT of patients with AMI, largely demonstrating that Black patients who initially present to hospitals without revascularization capabilities are less likely to be transferred to hospitals with revascularization capabilities.20, 23, 26 There is also suggestion of lower transfer rates for Black and Hispanic patients hospitalized with sepsis25 and for Hispanic patients with select conditions (as described above)24, 25, 39, 40 compared with White patients. Interestingly, our results did not corroborate the differences in transfer rates among patients hospitalized with AMI seen in the existing literature on this topic. This may be explained by the fact that, over time, as percutaneous intervention (PCI) has become more widely available, not only has need for transfer declined overall, but well-defined criteria for who to transfer may have ameliorated previously described disparities. It is also possible that the NIS lacks availability of essential confounders, e.g., hospital availability of cardiac catheterization services,30 which were adjusted for in other evaluations. For diseases such as CHF and GIB, where there are less established criteria for transfer than for AMI, the decision to transfer is potentially more discretionary and therefore more prone to bias, which is prevalent in many other aspects of health care.41, 42
Our results also demonstrated that patients with underinsurance and patients residing in zip codes with lower median income had lower adjusted odds of IHT, suggesting additional disparity by socioeconomic status, which is commonly described in other aspects of healthcare access.8, 43, 44 Several previous studies have demonstrated that underinsurance is associated with lower rates of transfer similar to our results,1, 3, 21, 24, 26 while others have demonstrated underinsurance is associated with higher rates of transfer.18, 27,28,29, 39, 45,46,47,48,49,50,51,52 Notably, the latter studies primarily involve patient transfers within the emergency room rather than for inpatients, which arguably confers disparate financial risk to hospitals (i.e., hospitals may be incentivized to transfer patients prior to admission to avoid being responsible for potentially lower reimbursement rates for services provided).21 These incentives may be effectively reversed for patients that are already admitted to the hospital. Nevertheless, in our study, there was little change in the association between race/ethnicity and transfer after accounting for socioeconomic variables in our successive analyses, making this explanation less likely to account for the observed associations between race/ethnicity and transfer.
Thus, based on our results, there appear to be residual racial/ethnic disparities in IHT among select patients hospitalized at community hospitals after accounting for differences in location of hospitalization and socioeconomic status. While our study cannot explain the underlying reasons driving these observed disparities, we offer several hypotheses. One possibility is that the observed disparities are due to bias among providers that influence the decision to transfer, as has been demonstrated in other aspects of health care.41, 42, 53 This is also suggested by our findings that women had significantly lower odds of transfer than men, indicating the potential existence of gender biases in addition to those pertaining to race/ethnicity. Second, it is possible that Black and Hispanic patients are less likely to request transfer. Transfer is frequently initiated by patient or family member request rather than medical necessity alone.7 However, Black and Hispanic patients may have more comfort with receiving care at familiar hospitals,54 less comfort with requesting transfer due to mistrust in the healthcare system,55 or less able to request transfer due to language barriers. Third, it is possible that these results are partially or solely reflective of unmeasured confounding, as discussed below under Limitations. Lastly, it should be emphasized that IHT is a complex process with many factors that influence decision-making. Therefore, any observed disparities are most likely due to the interplay of the above possible explanations. Indeed, health inequities by race and ethnicity are attributable to multiple factors.8, 56,57,58
It should also be noted that, while this study describes disparities in IHT by race/ethnicity, we did not examine clinical outcomes of these patients. Existent literature suggests that, in select patients, transfer is associated with worse clinical outcomes including greater mortality, longer length of stay, and greater costs.4, 24, 38 Therefore, these observed disparities may paradoxically protect the affected patient groups from worse outcomes. Even if this is the case, it does not justify the differential management of patients based on non-clinical factors and points toward potential health inequities, or differences in treatment rooted in systematic racial, economic, and social injustice.8, 33 Moreover, some transfers are clearly justified and associated with improved outcomes, and depriving certain patient populations of these benefits likely has adverse consequences.38
This study is subject to several limitations. First, although we used nationally representative data, administrative data is subject to potential inaccuracies in variable coding. Coding of race/ethnicity, Hispanic ethnicity in particular, is often fraught with inaccuracies.59,60,61 Specific to the NIS data, the variable for “race” is used for race and ethnicity designations. Thus, “Hispanic” patients included in this study were unable to identify as “Black” or “White,” and therefore may consist of a heterogenous population. Second, we were unable to account for the reason for transfer, which is not documented in NIS. We assume that the majority of patients who undergo IHT do so to receive necessary care unavailable at their original hospital, but we recognize that transfer is also initiated based on provider and/or patient preference even if the original hospital is capable of caring for a patient’s condition.7, 62 As discussed, understanding the underlying reason for transfer may help explain our observed findings and should be examined in future research on this topic. Third, we assume that patients who underwent transfer to another acute care facility received additional care at the receiving hospital, though we cannot confirm that this occurred. Forth, the NIS dataset includes individual hospital admissions rather than individual patients. We were therefore unable to account for patients who were admitted more than once during the time period of the study, which we assume is a small proportion of included hospitalizations. Fifth, by using a Bonferroni correction to account for multiple comparisons in the subgroup analyses and minimize type I error, we may have compromised power and increased type II error. Our odds ratio estimations could serve as effect size estimates for power calculations in future research exploring these hypotheses. Lastly, as with any administrative dataset, we were unable to account for unmeasured confounders that may have influenced our observed associations, including factors that may justify differences in IHT by race/ethnicity.
To conclude, we identified disparities in IHT by race/ethnicity for common medical diagnoses. There were variations in these observed disparities by geographic region and primary diagnosis. Though there are several possible explanations for our observed results, given the known systemic biases that exist within our healthcare system, these findings emphasize the need for further investigation to clarify why such disparities exist and how they might be reduced to ensure equitable provision of care to all patients.